Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Gallbladder and biliary tract cancer"'
Publikováno v:
World Journal of Surgical Oncology, Vol 22, Iss 1, Pp 1-15 (2024)
Abstract Background Gallbladder and biliary tract cancer (GBTC) is a significant health burden in China, exacerbated by the rising prevalence of high body mass index (BMI). Understanding the trends and factors contributing to mortality and disability
Externí odkaz:
https://doaj.org/article/8af7f737a8df4bcd92d9e98d3d0be917
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
ObjectivesOur aim was to explore the disease burden caused by gallbladder and biliary tract cancer globally, regionally, and nationally, by age and sex.MethodsThe absolute number of cases and age-standardized rates (ASR) of incidence, prevalence, mor
Externí odkaz:
https://doaj.org/article/7b3d637ef7a44772b5b793f76014b8e2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Heinz-Josef Klümpen, Jenny Shannon, Lars Henrik Jensen, Eik Vettorazzi, Silke Schrum, David Goldstein, Björn Nashan, Dirk Arnold, Alexander Stein, Ansgar W. Lohse, John N. Primrose, Henning Wege, John Bridgewater
Publikováno v:
Stein, A, Arnold, D, Bridgewater, J, Goldstein, D, Jensen, L H, Klumpen, H J, Lohse, A W, Nashan, B, Primrose, J, Schrum, S, Shannon, J, Vettorazzi, E & Wege, H 2015, ' Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial)-a randomized, multidisciplinary, multinational phase III trial ', B M C Cancer, vol. 15, 564 . https://doi.org/10.1186/s12885-015-1498-0
BMC Cancer
BMC cancer, 15(1). BioMed Central
BMC Cancer
BMC cancer, 15(1). BioMed Central
Background Despite complete resection, disease-free survival (DFS) of patients with cholangiocarcinoma (CCA) is less than 65 % after one year and not more than 35 % after three years. For muscle invasive gallbladder carcinoma (GBCA), prognosis is eve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7ebe129a388e7d574222e6f51186d53
https://findresearcher.sdu.dk:8443/ws/files/134109254/Adjuvant_chemotherapy_with_gemcitabine_and_cisplatin_compared_to_observation_after_curative_intent_resection_of_cholangiocarcinoma_and_muscle_invasive_gallbladder_carcinoma.pdf
https://findresearcher.sdu.dk:8443/ws/files/134109254/Adjuvant_chemotherapy_with_gemcitabine_and_cisplatin_compared_to_observation_after_curative_intent_resection_of_cholangiocarcinoma_and_muscle_invasive_gallbladder_carcinoma.pdf
Autor:
Zhan Z; Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, 350014, China., Chen X; Department of Operation, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, 350014, China., Xu S; Department of Hepatobiliary and Pancreatic Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, 350014, China., Li Q; Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, 350014, China., Yu J; Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, 350014, China., Guo Z; Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, 350014, China., Chen B; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, Fujian, 350014, China. chenbj1208@fjmu.edu.cn.
Publikováno v:
World journal of surgical oncology [World J Surg Oncol] 2024 Nov 12; Vol. 22 (1), pp. 296. Date of Electronic Publication: 2024 Nov 12.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.